Failure of colchicine to reduce inhaled triamcinolone dose in patients with asthma.
Newman
K B
KB
Division of Pulmonary Medicine, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colo, USA.
Mason
U G
UG
Buchmeier
A
A
Schmaling
K B
KB
Corsello
P
P
Nelson
H S
HS
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy*; D001772:Blood Cell Count; D003078:Colchicine / Q000008:administration & dosage* / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000627:therapeutic use; D006074:Gout Suppressants / Q000008:administration & dosage* / Q000627:therapeutic use*; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010976:Platelet Count; D012129:Respiratory Function Tests; D012720:Severity of Illness Index; D000637:Transaminases / Q000032:analysis; D014221:Triamcinolone / Q000008:administration & dosage* / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D005938:Glucocorticoids; D006074:Gout Suppressants; D014221:Triamcinolone; D007073:Immunoglobulin E; D000637:Transaminases; D003078:Colchicine